As for the latter, TRIM-targeted therapies in cancer are gaining momentum over the past years, such as the TRIM8-targeting approaches for chemo-resistant colorectal cancer [43] or the TRIM24-targeting options for glioblastoma [44]. The gene discussed is TRAT1; the disease is cancer.